Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 28, 2014; 20(32): 11363-11369
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11363
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11363
Table 3 Classification of groups according to mean tacrolimus concentration, death rate and related side effects in respective categories
| Group | 1 | 2 | 3 | 4 |
| TC interval (ng/mL) | 0-5 | 5-7 | 7-10 | 10-15 |
| Total number | 21 | 57 | 119 | 38 |
| Number of death | 8 | 9 | 23 | 7 |
| Cause of death | ||||
| MODS | 4 | 4 | 2 | 1 |
| Tumor recurrence | 2 | 4 | 13 | 3 |
| Graft loss | 1 | 1 | 0 | 1 |
| Others | 1 | 0 | 8 | 2 |
| Rejection | 2 | 14 | 16 | 6 |
| Infection | 6 | 14 | 24 | 11 |
| Renal insufficiency | 2 | 2 | 2 | 1 |
| Tumor recurrence | 5 | 7 | 19 | 5 |
| Metabolic disorder | 6 | 8 | 15 | 5 |
- Citation: Jia JJ, Lin BY, He JJ, Geng L, Kadel D, Wang L, Yu DD, Shen T, Yang Z, Ye YF, Zhou L, Zheng SS. ''Minimizing tacrolimus'' strategy and long-term survival after liver transplantation. World J Gastroenterol 2014; 20(32): 11363-11369
- URL: https://www.wjgnet.com/1007-9327/full/v20/i32/11363.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i32.11363